- Home
- PDLB vs AQST Comparison
PDLB vs AQST Comparison
Compare PDLB & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- AQST
- Stock Information
- Founded
- PDLB 1960
- AQST 2004
- Country
- PDLB United States
- AQST United States
- Employees
- PDLB N/A
- AQST N/A
- Industry
- PDLB
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- PDLB
- AQST Health Care
- Exchange
- PDLB Nasdaq
- AQST Nasdaq
- Market Cap
- PDLB 251.3M
- AQST 254.1M
- IPO Year
- PDLB 2017
- AQST 2018
- Fundamental
- Price
- PDLB $13.59
- AQST $2.76
- Analyst Decision
- PDLB
- AQST Strong Buy
- Analyst Count
- PDLB 0
- AQST 5
- Target Price
- PDLB N/A
- AQST $11.40
- AVG Volume (30 Days)
- PDLB 41.6K
- AQST 984.2K
- Earning Date
- PDLB 04-25-2025
- AQST 05-12-2025
- Dividend Yield
- PDLB N/A
- AQST N/A
- EPS Growth
- PDLB 148.96
- AQST N/A
- EPS
- PDLB 0.60
- AQST N/A
- Revenue
- PDLB $86,682,000.00
- AQST $57,561,000.00
- Revenue This Year
- PDLB $10.97
- AQST N/A
- Revenue Next Year
- PDLB $8.59
- AQST $39.51
- P/E Ratio
- PDLB $22.61
- AQST N/A
- Revenue Growth
- PDLB 12.39
- AQST 13.79
- 52 Week Low
- PDLB $8.42
- AQST $2.20
- 52 Week High
- PDLB $13.97
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- PDLB 73.44
- AQST 48.51
- Support Level
- PDLB $13.19
- AQST $2.65
- Resistance Level
- PDLB $13.58
- AQST $3.05
- Average True Range (ATR)
- PDLB 0.35
- AQST 0.16
- MACD
- PDLB 0.21
- AQST 0.00
- Stochastic Oscillator
- PDLB 97.13
- AQST 50.51
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.